Introduction: Wuxi Vertex Medical Devices Co., Ltd. was settled in Science and Technology Park in July 2006, with a registered capital of 1.5 million yuan, and has obtained 20 million venture capital from the U.S. SIG Fund, and is now going through the procedure of capital increase, and the core members of the company are all expatriates or foreign students, and the company has been established so far with the good prospect of the project and the high quality of the core team of the company has been awarded the national and local science and technology funds, A number of local science and technology funds, products to undertake the 2008 National Innovation Fund project and successfully passed the acceptance, the founder of the company Yang Libo was named "Jiangsu Province, high-level innovation and entrepreneurial talent introduction program" to introduce talent, the project products to obtain the Jiangsu Province, science and technology to support the development of social capital support, the company as a key support for the Wuxi "530" enterprises, by the local Science and Technology Bureau and the Drug Administration Department of concern. As a key enterprise supported by Wuxi "530", the company has received much attention from the local science and technology bureau and drug supervision department. ;br; The company's main product, high-precision intelligent insulin pump, is a new generation of portable high-precision automatic insulin injection device integrating software technology, embedded integrated circuit technology, automated control system technology, precision instrumentation and medical polymer material technology. The successful research and development of this product breaks the long-term monopoly of foreign products in this industry, and will provide more economical and reliable treatment programs and intelligent and precise cutting-edge products for the vast number of diabetic patients at home and abroad. ;br;
Legal representative: Li Qun
Establishment date: 2006-07-26
Registered capital: RMB 1,587,302,000
Region: Jiangsu Province
Unified social credit code: 91320213790894650M
Operating status: active
Operating country: China
Our industry: China, China and Taiwan
Our company is a member of the China National Association of Diabetes Control (CNAC), which is the largest association in China. /p>
Industry: Manufacturing
Company Type: Limited Liability Company (Sino-foreign equity joint venture)
Personnel Size: 100-499
Enterprise Address: No. 35-209, Changjiang South Road, Xinwu District, Wuxi City
Business Scope: Class III, 6854, Operating Room, Emergency Room, Diagnostic and Treatment Room Equipment and Apparatus,6866 Medical Polymer Materials and Products, R&D, Production and Sales. Polymer materials and products research and development, production, technical services; stethoscope research and development, production, technical services. (The above scope of business does not include national prohibited, restricted items, involving administrative licensing, subject to licensing before operating; involving special approval, subject to approval before operating) (projects subject to approval by law, subject to the approval of the relevant departments before carrying out business activities)